Arrowhead Pharmaceuticals, Inc. SEC filings ARWR
Arrowhead Pharmaceuticals, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Apr 30, 2010. Its latest annual report, Form ARS, was filed on Jan 27, 2026 for the period ended Jan 26, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 4, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (material agreement, new debt). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Feb 5, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Feb 10, 2025 | Dec 31, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Feb 6, 2024 | Dec 31, 2023 |
| 10-Q | Quarterly report | Aug 7, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 2, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Feb 6, 2023 | Dec 31, 2022 |
| 10-Q | Quarterly report | Aug 4, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Feb 2, 2022 | Dec 31, 2021 |
| 10-Q | Quarterly report | Aug 5, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 4, 2021 | Mar 31, 2021 |
| 10-Q | Quarterly report | Feb 4, 2021 | Dec 31, 2020 |
| 10-Q | Quarterly report | Aug 5, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | May 7, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | Feb 5, 2020 | Dec 31, 2019 |
| 10-Q | Quarterly report | Aug 5, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | May 8, 2019 | Mar 31, 2019 |
| 10-Q | Quarterly report | Feb 7, 2019 | Dec 31, 2018 |
| 10-Q | Quarterly report | Aug 7, 2018 | Jun 30, 2018 |
| 10-Q | Quarterly report | May 8, 2018 | Mar 31, 2018 |
| 10-Q | Quarterly report | Feb 9, 2018 | Dec 31, 2017 |
| 10-Q | Quarterly report | Aug 3, 2017 | Jun 30, 2017 |
| 10-Q | Quarterly report | May 3, 2017 | Mar 31, 2017 |
| 10-Q | Quarterly report | Feb 6, 2017 | Dec 31, 2016 |
| 10-Q | Quarterly report | Aug 9, 2016 | Jun 30, 2016 |
| 10-Q | Quarterly report | May 10, 2016 | Mar 31, 2016 |
| 10-Q | Quarterly report | Feb 9, 2016 | Dec 31, 2015 |
| 10-Q | Quarterly report | Aug 4, 2015 | Jun 30, 2015 |
| 10-Q | Quarterly report | May 11, 2015 | Mar 31, 2015 |
| 10-Q | Quarterly report | Feb 9, 2015 | Dec 31, 2014 |
| 10-Q | Quarterly report | Aug 12, 2014 | Jun 30, 2014 |
| 10-Q | Quarterly report | May 6, 2014 | Mar 31, 2014 |
| 10-Q | Quarterly report | Feb 4, 2014 | Dec 31, 2013 |
| 10-Q | Quarterly report | Aug 7, 2013 | Jun 30, 2013 |
| 10-Q | Quarterly report | May 9, 2013 | Mar 31, 2013 |
| 10-Q | Quarterly report | Feb 13, 2013 | Dec 31, 2012 |
| 10-Q | Quarterly report | Aug 13, 2012 | Jun 30, 2012 |
| 10-Q | Quarterly report | May 8, 2012 | Mar 31, 2012 |
| 10-Q | Quarterly report | Feb 9, 2012 | Dec 31, 2011 |
| 10-Q | Quarterly report | Aug 8, 2011 | Jun 30, 2011 |
| 10-Q | Quarterly report | May 12, 2011 | Mar 31, 2011 |
| 10-Q | Quarterly report | Feb 10, 2011 | Dec 31, 2010 |
| 10-Q | Quarterly report | Aug 12, 2010 | Jun 30, 2010 |
| 10-Q | Quarterly report | May 13, 2010 | Mar 31, 2010 |
Showing 50 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ARWR (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- DE
- Headquarters
- Pasadena, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 879407
- Former names
- ARROWHEAD RESEARCH CORP (until Apr 6, 2016); INTERACTIVE GROUP INC (until Jan 9, 2004); INTERACTIVE INC (until Feb 13, 2002)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.